Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

OTHER 23 NIH 11 INDUSTRY 2 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

sargramostim 1 pembrolizumab 1 Injections 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Exercise 1 Cryotherapy 1 Cryosurgery 1 Clofarabine 1 Celecoxib 1 Capecitabine 1 ADI PEG20 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × FED × Celecoxib × Clear all

NCT00108186 2014-10-29

Celecoxib Treatment for Lung Cancer

VA Office of Research and Development

Phase 1 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡